Catalent lays off 350 workers over change in demand from a ‘large customer’ news2025-08-20T11:20:59+00:00August 20th, 2025|Endpoints News|
Irish pharma exports to the US decrease after months of stockpilingnews2025-08-19T15:12:03+00:00August 19th, 2025|Endpoints News|
Trump executive order focuses on stockpiling raw materials for ‘critical’ drugsnews2025-08-14T14:12:16+00:00August 14th, 2025|Endpoints News|
More layoffs at Evotec; Savara to work with Fujifilm as manufacturing partnernews2025-08-14T13:22:58+00:00August 14th, 2025|Endpoints News|
US tariffs could undo generic drugmakers’ efforts to be less reliant on Chinese raw materials, experts saynews2025-08-13T11:00:20+00:00August 13th, 2025|Endpoints News|
AbbVie announces $195M API plant outside of Chicagonews2025-08-12T19:39:20+00:00August 12th, 2025|Endpoints News|
Sanofi, Regeneron’s cholesterol drug is in short supply in Chinanews2025-08-12T14:04:43+00:00August 12th, 2025|Endpoints News|
New FDA program aims to speed up construction of US manufacturing sites news2025-08-07T15:45:47+00:00August 7th, 2025|Endpoints News|
J&J gets CRL over manufacturing issues; Charles River stays afloatnews2025-08-07T15:16:08+00:00August 7th, 2025|Endpoints News|
Scholar Rock expects September PDUFA for spinal muscular atrophy drug to stay unchanged despite CDMO woes news2025-08-07T13:16:44+00:00August 7th, 2025|Endpoints News|
